Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc. Common Stock (NY:BHC)

4.605 -0.065 (-1.39%)
Streaming Delayed Price Updated: 12:03 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
7 Stock Price Predictions That Are Actually Worth Listening To
Investors may take advantage of analyst stock price predictions beyond the recent share price to discover promising investments. 
Via InvestorPlace
Recap: Bausch Health Companies Q2 Earnings
  Bausch Health Companies (NYSE:BHC) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Bausch Health Companies... 
Via Benzinga
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings... 
Via Benzinga
BHC Stock Continues to Fall as Bausch Health Responds to Court Decision
Although Bausch Health promises to fight back against an unfavorable patent protection ruling, BHC stock is still hurting. 
Via InvestorPlace
Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday's Mid-Day Session
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
  
Via Benzinga
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Benzinga Before The Bell: Apple's Strong China Revenue, Amazon's EV Partnership, Jack Ma To Cede Control Of Ant Financial And Other Top Financial Stories Friday, July 29
Reuters Tencent’s Overseas Ambitions Face Resistance From India 
Via Benzinga
Bausch Health To Appeal Expected Court Decision On Xifaxan Patents
Yesterday, Bausch Health Companies Inc (NYSE: BHC) stock closed 50% lower after the reports on the order on patent litigation over Xifaxan (rifaximin). 
Via Benzinga
Nasdaq Rises 100 Points; US Economy Shrinks Again In Q2
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Thursday. 
Via Benzinga
'Well-Established' Eye Health Company Bausch + Lomb Gets Outperform Rating From This Analyst
Via Benzinga
Expert Ratings for Bausch Health Companies
Bausch Health Companies (NYSE:BHC) has observed the following analyst ratings within the last quarter: 
Via Benzinga
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,... 
Via Benzinga
Why Bausch Health's Market Cap Is Being Cut In Half Thursday: 'A Near Worst-Case Scenario'
Shares of global health company Bausch Health Companies Inc (NYSE: BHC) are plunging Thursday after a Delaware federal judge issued an oral order on patents related to the company's Xifaxan drug. 
Via Benzinga
Bausch Health (BHC) Stock Plunges 50% on Patent News
With Bausch Health losing a critical patent battle enabling its key drug to suffer generic competition, BHC stock veritably crumbled. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 108 companies set new 52-week lows. 
Via Benzinga
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan. 
Via Benzinga
Nasdaq Dips Over 100 Points; Meta Earnings Miss Estimates
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Thursday. 
Via Benzinga
NIO Stock Falls as Grizzly Research Targets the EV Maker in New Short Report
Shares of NIO stock are sinking lower today following the release of a Grizzly Research short report. Here's what you should know. 
Via InvestorPlace
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation... 
Via Benzinga
Opening Day: Golden Sun Rises In Debut As Ivanhoe Electric Delays IPO
Chinese tutorial services provider Golden Sun Education opened for trading this week, with its shares surging almost 300% following a $17.6 million initial public offering. Meanwhile, Ivanhoe Electric... 
Via Talk Markets
Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session
Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider. 
Via Benzinga
Bausch Health to Postpone Its Planned Initial Public Offering (Ipo) of Its Solta Medical Skin-care Division Due to Market Instability.
The IPO process for Solta drew "substantial investor interest," according to a statement released by Bausch Health. "However, the business 
Via Best Stocks
Topics Initial Public Offering
Exposures Securities Market
Cramer Gives His Opinion On Equinix, Bausch Health And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Bausch Health Companies Inc. 
Via Benzinga
Bausch Health Companies Earnings Perspective: Return On Capital Employed
Benzinga Pro data, Bausch Health Companies (NYSE:BHC) reported Q1 sales of $1.92 billion. Earnings fell to a loss of $66.00 million, resulting in a 191.67% decrease from last quarter. 
Via Benzinga
Looking Into Bausch Health Companies's Return On Capital Employed
Bausch Health Companies (NYSE:BHC) brought in sales totaling $1.92 billion during Q1 according to data provided by Benzinga Pro. However, earnings decreased 191.67%, resulting in a loss of $66.00... 
Via Benzinga
3 Value Stocks That Could 2x in a Recession
It might be tempting to say that valuation metrics are no longer useful for certain kinds of value stocks, but you need to adjust your focus. 
Via InvestorPlace
Billionaire Carl Icahn Is Betting Big on These 5 Stocks. Here’s Why.
Famed corporate raider Carl Icahn still manages a billion dollar portfolio for his family office. Here's what he's betting on. 
Via InvestorPlace
Jim Cramer Shares His Opinion On Roblox, Century Aluminum And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Roblox Corp (NASDAQ: RBLX) as it is not making money. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.